ArticleActive
Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A57560
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: May 1, 2025
Updated: December 31, 2025
See LCD L36811Policy Summary
This billing guideline specifies that the Prosigna® breast cancer assay must be billed using CPT 81520 with 1 unit of service and the appropriate ICD-10-CM diagnosis code. Claims must include the DEX Z-Code™ identifier adjacent to the CPT code in the designated comment/narrative fields for Part B (Loop 2400/SV101-7 or Box 19) and Part A (SV202-7 or Block 80) claim types; coverage and clinical eligibility are determined by LCD MolDX: Breast Cancer Assay: Prosigna® (L36811).
Coverage Criteria Preview
Key requirements from the full policy
"Report the Prosigna® breast cancer assay using CPT code 81520 when the test is performed per coverage criteria in LCD MolDX: Breast Cancer Assay: Prosigna® (L36811)."
Sign up to see full coverage criteria, indications, and limitations.